# Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule

> **NCT00513409** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 163 (actual)

## Conditions studied

- Infections, Streptococcal

## Interventions

- **BIOLOGICAL:** Synflorix
- **BIOLOGICAL:** Infanrix Hexa
- **BIOLOGICAL:** Havrix

## Key facts

- **NCT ID:** NCT00513409
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08-22
- **Primary completion:** 2008-02-20
- **Final completion:** 2008-08-28
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00513409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00513409, "Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00513409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*